Finasteride and minoxidil utilize different mechanisms to treat androgenetic alopecia
the verdict
SUPPORTED
the evidence backs this
confidence 78/100
Finasteride and minoxidil operate through distinct biological pathways; finasteride acts as a 5-alpha-reductase inhibitor targeting androgen metabolism, whereas minoxidil serves as a non-androgen-targeted therapy.
Evidence for · 3
Updates in Treatment for Androgenetic Alopecia.
2025 · cited by 2
This paper highlights that finasteride functions as a 5-alpha-reductase inhibitor targeting androgen levels, whereas minoxidil acts via a non-androgen-targeted mechanism to treat androgenetic alopecia.
See more details
More for · 2
Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia.
2026 · cited by 0
This article distinguishes between traditional therapies like minoxidil and finasteride, which engage different biological pathways to address follicular degeneration.
Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies.
2026 · cited by 0
This review notes that genetic and pharmacogenetic studies link minoxidil bioactivation and 5-alpha-reductase activity to distinct mechanistic pathways in treating male pattern hair loss.